A new global roadmap addresses a serious gap in pregnancy care: proven checks and treatments still do not reach many women who need them. WHO and partners launched the plan in October to tackle disorders involving high blood pressure during pregnancy. These conditions affect an estimated ten to fifteen percent of pregnancies worldwide and account for around sixteen percent of maternal deaths. The roadmap covers the period from 2026 to 2035 and beyond, linking research with practical improvements in health systems.
The obstacles include unreliable access to blood-pressure measurement, medicines, trained staff and emergency services. Weak referral arrangements can delay care when a complication becomes severe. Research also needs to address the shortage of medicines specifically developed for certain pregnancy-related disorders. Earlier discussions involving more than 140 partners identified twenty priority research questions. The initiative brings these strands together rather than treating innovation and delivery as separate problems. Its central challenge is ensuring that effective care depends less on a woman's income or location.